Emergent BioSolutions Inc. — Director's Dealing 2019

Mar 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2019-03-11

Reporting Person: Havey Adam (EVP, Business Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-11	Common Stock	S	2430	$56.93	Disposed	32240	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.